Retatrutide shows marked relief of knee osteoarthritis in two randomized trials

Two new randomized trials of the GLP-1 drug retatrutide showed marked relief of knee osteoarthritis, presented at AHA26 and published in NEJM. Prior work indicated some of the GLP-1 benefit for knee osteoarthritis is independent of weight loss.

Detected & updated continuously · Source: Nebula